YOLFTbeta
13

DHP Korea Co. Ltd

131030 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

5,960.00KRW-10.00 (-0.17%)

Price History

Full chart

Market Stats

Previous Close5,970.00
Open5,970.00
Day Range5,910.00 – 6,090.00
52-Week Range4,610.00 – 20,750.00
Volume30.12K
Market Cap108.06B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.05
50-Day Avg5,733.50
200-Day Avg7,696.93

About

OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company was formerly known as DHP Korea Co., Ltd. OPTUS Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Cheongju, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Dong-Hwa Han
  • Employees0
  • Headquarters50 Osongsaengmyeong 6-ro, Cheongju, South Korea, Korea
  • Websitehttps://www.optuspharm.com

Leadership

  • Mr. Dong-Hwa HanChief Executive Officer and President

Financials

Income Statement

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue32.57B38.56B44.72B49.81B49.62B60.44B60.83B57.32B58.66B72.43B81.90B87.16B
Growth (%)-+18.40%+15.98%+11.38%-0.37%+21.80%+0.64%-5.77%+2.34%+23.47%+13.09%+6.42%
Cost of Revenue13.18B15.39B19.60B22.13B22.49B23.52B22.50B24.79B26.95B31.00B37.19B38.98B
Gross Profit19.38B23.17B25.12B27.68B27.13B36.92B38.32B32.53B31.71B41.43B44.71B48.18B
Gross Margin59.52%60.09%56.16%55.57%54.68%61.09%63.00%56.75%54.05%57.20%54.59%55.28%
Operating Expense10.24B12.85B13.73B15.06B16.42B21.73B22.82B22.05B26.45B33.24B36.13B39.31B
Operating Income9.14B10.32B11.38B12.62B10.72B15.19B15.51B10.47B5.26B8.19B8.59B8.88B
Operating Margin28.06%26.76%25.45%25.33%21.59%25.13%25.49%18.27%8.96%11.30%10.49%10.18%
EBITDA--------10.38B17.33B16.16B15.83B
EBITDA Margin--------17.69%23.93%19.73%18.16%
Net Income9.52B10.30B11.50B12.88B10.00B14.60B14.41B9.89B5.01B10.76B10.31B11.36B
Net Income Margin29.23%26.71%25.71%25.86%20.16%24.15%23.68%17.26%8.54%14.86%12.59%13.03%
R&D88.49M2.02B1.25B551.99M757.72M1.15B821.84M1.11B1.34B1.38B1.88B1.73B
R&D as % of Total Revenue0.27%5.25%2.79%1.11%1.53%1.90%1.35%1.94%2.29%1.91%2.30%1.99%
Interest Expense00000017.61M8.88M85.89M124.40M97.24M69.34M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.03%0.02%0.15%0.17%0.12%0.08%

Balance Sheet

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets67.39B73.14B83.85B94.57B103.91B118.97B129.90B140.04B136.24B149.46B166.50B191.06B
Total Liabilities10.90B7.65B8.59B8.02B9.00B11.22B11.01B13.02B11.77B15.01B22.77B26.05B
Total Equity56.49B65.49B75.26B86.55B94.90B107.75B118.88B127.02B124.47B134.45B143.73B165.01B
Cash27.12B28.24B42.00B54.45B33.87B35.15B42.42B5.31M3.75M17.81B20.91B20.67B
Total Debt-----72.91M352.32M-----

Cash Flow

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow12.82B11.08B12.04B18.30B15.05B16.83B17.45B7.07B2.05B12.44B8.90B16.23B
Investing Cash Flow-8.98B-8.09B3.35B-2.23B-33.99B-13.83B-6.41B-15.22B-16.27B-2.93B2.29B-
Financing Cash Flow-895.89M-1.87B-1.63B-3.63B-1.63B-1.71B-3.76B-1.72B-7.93B-2.10B-2.14B-
Capital Expenditure4.48B6.87B1.65B1.16B689.26M3.80B5.84B10.63B6.00B3.33B25.74B45.04B
Free Cash Flow------11.60B-3.56B-3.96B9.11B-16.84B-28.82B
Dividends Paid1.61B1.61B1.63B1.63B1.63B1.63B1.63B1.60B1.60B1.52B1.53B-
FCF to OCF------66.51%-50.30%-193.37%73.24%-189.06%-177.60%
Dividend Paid to FCF------14.07%-45.10%-40.56%16.65%-9.06%-

Earnings

Report DateMar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013May 28, 2014Aug 14, 2014Nov 14, 2014Jan 19, 2015May 16, 2015Aug 14, 2015Nov 11, 2015Feb 26, 2016May 11, 2016Aug 11, 2016Nov 10, 2016Feb 13, 2017May 14, 2017Aug 10, 2017Nov 12, 2017Feb 21, 2018May 13, 2018Aug 13, 2018Nov 13, 2018Mar 4, 2019May 14, 2019Aug 13, 2019Nov 13, 2019Feb 25, 2020May 13, 2020Aug 18, 2020Nov 12, 2020Mar 3, 2021May 17, 2021Aug 17, 2021Nov 18, 2021Feb 23, 2022May 17, 2022Aug 16, 2022Nov 14, 2022Mar 1, 2023May 15, 2023Aug 15, 2023Nov 15, 2023Feb 21, 2024May 13, 2024Aug 20, 2024Nov 14, 2024Mar 28, 2025Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------------------------------
EPS Actual17.3918.2523.3222.5521.9023.6224.2323.0419.2016.7516.23121.81145.30163.00163.00135.89162.23192.97139.74148.17183.97184.99187.06227.25232.68238.5090.49180.75190.00184.9757.01212.79246.05230.14205.11258.29297.63149.83185.99116.31105.32175.75219.25139.9035.99112.9127.06135.15216.91148.58207.54157.48158.7099.59259.2176.86186.32209.16259.20149.52224.73
Surprise-------------------------------------------------------------
Timing------------Pre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market--------------------------

Key Statistics & Ratios

Market Cap108.06B
Enterprise Value60.60B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.14
Price / Book0.56
Revenue (TTM)94.47B
Gross Profit (TTM)53.05B
EBITDA15.18B
Profit Margin14.56%
Operating Margin9.42%
Return on Equity8.40%
Return on Assets3.42%
Shares Outstanding17.37M
Shares Float9.31M
Beta-0.05
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
100.00Dec 27, 2023
20221×
100.00Dec 28, 2022
20211×
100.00Dec 29, 2021
20201×
100.00Dec 29, 2020
20191×
100.00Dec 27, 2019
20181×
100.00Dec 27, 2018
20171×
100.00Dec 27, 2017
20161×
100.00Dec 28, 2016
20151×
100.00Dec 29, 2015
20141×
100.00Dec 29, 2014